Lexpos News

/Lexpos News/

MHRA Class 4 Medicines Defect Information: MacroBID 100mg Prolonged-Release Capsules (ADVANZ PHARMA)

Class 4 Medicines Defect Information: MacroBID 100mg Prolonged-Release Capsules (ADVANZ PHARMA) Drug alert number: EL (22)A/50 Date issued: 05 December 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: MacroBID 100mg Prolonged-Release Capsules, PL 12762/0052 Batch Number Expiry Date Pack Size First Distributed 21001 05 [...]

The post MHRA Class 4 Medicines Defect Information: MacroBID 100mg Prolonged-Release Capsules (ADVANZ PHARMA) appeared first on PSNC Website.

By |December 5th, 2022|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: MacroBID 100mg Prolonged-Release Capsules (ADVANZ PHARMA)

November 2022 Price Concessions Final Update

The Department of Health and Social Care (DHSC) has today (02/12/2022) granted the following final list of price concessions for November 2022: Drug Pack size Price concession Nitrofurantoin 100mg tablets 28 £14.61 Nitrofurantoin 50mg tablets 28 £13.27 The DHSC previously announced (30/11/2022) the following list of price concessions: Drug Pack size Price concession Aripiprazole 5mg tablets 28 [...]

The post November 2022 Price Concessions Final Update appeared first on PSNC Website.

By |December 2nd, 2022|Lexpos News|Comments Off on November 2022 Price Concessions Final Update

Protecting Pharmacy Funding: PSNC seeks contractor views

PSNC met last week and considered the critical situation facing many community pharmacy businesses as staffing and other costs continue to rise unchecked. Our ongoing priority is to make strong and urgent representations to Government to seek an emergency funding injection into the sector as well as relief from business rates. We are also discussing [...]

The post Protecting Pharmacy Funding: PSNC seeks contractor views appeared first on PSNC Website.

By |December 1st, 2022|Lexpos News|Comments Off on Protecting Pharmacy Funding: PSNC seeks contractor views

Protecting Pharmacy Funding: A video update from PSNC’s CEO

PSNC Chief Executive Janet Morrison has recorded a video update for community pharmacy contractors following PSNC’s November Committee meeting. Janet opens the video by emphasising that both PSNC staff and Committee Members know how difficult things are at the moment, and says that she wants to give some honest feedback on where the sector is [...]

The post Protecting Pharmacy Funding: A video update from PSNC’s CEO appeared first on PSNC Website.

By |December 1st, 2022|Lexpos News|Comments Off on Protecting Pharmacy Funding: A video update from PSNC’s CEO

5 products added to the Discount Not Deducted (DND) list from December 2022

Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 5 new products will be classed as ‘Drugs for which Discount is Not Deducted’ (DND) from 1 December 2022. This takes the total number of products granted DND status over the past [...]

The post 5 products added to the Discount Not Deducted (DND) list from December 2022 appeared first on PSNC Website.

By |December 1st, 2022|Lexpos News|Comments Off on 5 products added to the Discount Not Deducted (DND) list from December 2022